Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment-Reference-Cited by-同舟云学术

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment

Published:2016 Issue:19 Volume:55 Page:2877-2880
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Takazono Takahiro¹²,Sawai Toyomitsu³,Tashiro Masato¹,Saijo Tomomi²,Yamamoto Kazuko²,Imamura Yoshifumi²,Miyazaki Taiga¹²,Suyama Naofumi³,Izumikawa Koichi¹,Kakeya Hiroshi⁴,Yanagihara Katsunori⁵,Mukae Hiroshi²,Kohno Shigeru²

Affiliation:

1. Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan

2. Second Department of Internal Medicine, Nagasaki University Hospital, Japan

3. Department of Internal Medicine, Nagasaki Municipal Hospital, Japan

4. Department of Infection Control Science, Graduate School of Medicine, Osaka City University, Japan

5. Department of Laboratory Medicine, Nagasaki University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/55/19/55_55.6969/_pdf

Reference11 articles.

1. 1. Morrison VA. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis 59 Suppl 5: S360-S364, 2014.

2. 2. Takazono T, Izumikawa K, Yoshioka S, et al. Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review. Jpn J Infect Dis 65: 461-464, 2012.

3. 3. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50: 291-322, 2010.

4. 4. Vibhagool A, Sungkanuparph S, Mootsikapun P, et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin Infect Dis 36: 1329-1331, 2003.

5. 5. Kohno S, Kakeya H, Izumikawa K, et al. Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan. J Infect Chemother 21: 23-30, 2015.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryptococcosis Associated With Biologic Therapy: A Narrative Review;Open Forum Infectious Diseases;2024-06-26

2. Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports;World Journal of Gastroenterology;2023-01-28

3. Invasive Fungal Disease;Infectious Complications in Biologic and Targeted Therapies;2022

4. Fungal Infections Potentiated by Biologics;Infectious Disease Clinics of North America;2020-06

5. A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus–negative People in the United States;Clinical Infectious Diseases;2019-03-11